"Outpatient surgery center providing the highest quality care for patients."

During the past decade, Valley Gastroenterology Medical Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Valley Gastroenterology Medical Group" are "Crohn Disease" (2 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Valley Gastroenterology Medical Group" in a lesser frequency.

Most popular intervention types in "Valley Gastroenterology Medical Group" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Etrolizumab" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Valley Gastroenterology Medical Group" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Valley Gastroenterology Medical Group". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Valley Gastroenterology Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Valley Gastroenterology Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".